BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
What Are We Doing?
Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.
We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.
Who is BlueRock?
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform , we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
What Are We Doing?
Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.
We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.
The Role
BlueRock Therapeutics is seeking a Director, People Strategy Partner to join our People & Culture team, reporting to the Senior Director, People Strategy and Engagement. This role will serve as the primary People partner to the Chief Technical Operations Officer and Technical Operations leadership team, supporting one of BlueRock's largest and most complex functions.
The Director will translate business priorities into practical people strategies while providing hands-on support for organizational effectiveness, talent, employee relations, workforce planning, and core People processes. Success requires strong business acumen, sound judgment, and the ability to balance strategic partnership with operational execution.
Key Responsibilities
Business and People Partnership
· Serve as the primary People Strategy Partner to the Chief Technical Operations Officer and Technical Operations leadership team, translating business priorities into actionable people and workforce plans.
· Advise and coach leaders on organizational effectiveness, leadership capability, talent decisions, performance, engagement, retention, and organizational health.
· Provide hands-on guidance on complex employee relations matters, including performance concerns, workplace conflict, conduct issues, accommodations, and other sensitive employee situations.
· Lead or support timely, fair, and well-documented reviews of employee concerns in partnership with Legal, while coaching managers to address issues early, consistently, and effectively.
· Partner with the Senior Director, People Strategy and Engagement to align Technical Operations priorities with BlueRock's broader people strategy and employee…